Lincoln Pharmaceuticals Shareholding Pattern & Promoter Holding
Pharmaceuticals & Biotechnology · Latest pattern: Sep 2026
As of Sep 2026, promoters hold 49.78% of Lincoln Pharmaceuticals, FIIs hold 4.55%, DIIs hold 0.02% and the public holds 45.65%. Promoter holding was unchanged from Jun 2026.
Get an alert when Lincoln Pharmaceuticals reports results or its shareholding changes. Free account.
Promoters
49.78%
unchanged QoQ
FIIs
4.55%
−0.05 pp QoQ
DIIs
0.02%
−0.25 pp QoQ
Public
45.65%
+0.29 pp QoQ
Lincoln Pharmaceuticals shareholding, quarter by quarter
| Quarter | Promoters | FIIs | DIIs | Public | Shareholders |
|---|---|---|---|---|---|
| Sep 2026 | 49.78% | 4.55% | 0.02% | 45.65% | 29,272 |
| Jun 2026 | 49.78% | 4.60% | 0.27% | 45.36% | 29,396 |
| Mar 2026 | 49.78% | 5.20% | 1.08% | 43.94% | 28,303 |
| Dec 2025 | 49.78% | 4.70% | 0.01% | 45.51% | 31,026 |
| Sep 2025 | 49.78% | 4.73% | 0.01% | 45.49% | 32,370 |
| Jun 2025 | 49.78% | 5.13% | 0.01% | 45.08% | 31,784 |
| Mar 2025 | 49.78% | 5.00% | 0.00% | 45.23% | 31,867 |
| Dec 2024 | 49.78% | 5.16% | 0.00% | 45.07% | 31,848 |
| Sep 2024 | 49.78% | 5.19% | 0.00% | 45.04% | 31,330 |
| Jun 2024 | 49.78% | 3.95% | 0.04% | 46.24% | 29,967 |
| Mar 2024 | 49.54% | 3.93% | 0.05% | 46.49% | 31,375 |
| Dec 2023 | 49.81% | 3.22% | 0.06% | 46.92% | 29,316 |
Promoters · FIIs (foreign institutions) · DIIs (domestic institutions) · Public (retail & others). Percentages of total shares, from the quarterly pattern filed with the exchanges.
Value of the promoter stake
At a market capitalisation of ₹1.05k cr, the promoter group's 49.78% stake is worth ₹521 cr. A promoter group is usually a family, trust or holding company; this figure covers only this listed company and is not anyone's net worth.
Promoter holding in Pharmaceuticals & Biotechnology peers
Lincoln Pharmaceuticals shareholding: common questions
What is the promoter holding in Lincoln Pharmaceuticals?
Promoters hold 49.78% of Lincoln Pharmaceuticals as of Sep 2026. Their stake was unchanged from Jun 2026.
How much do FIIs hold in Lincoln Pharmaceuticals?
Foreign institutional investors (FIIs) held 4.55% of Lincoln Pharmaceuticals in Sep 2026, −0.05 pp versus Jun 2026.
How much do mutual funds and other DIIs hold in Lincoln Pharmaceuticals?
Domestic institutional investors (DIIs), which include mutual funds and insurers, held 0.02% of Lincoln Pharmaceuticals in Sep 2026, −0.25 pp versus Jun 2026.
Is the promoter holding in Lincoln Pharmaceuticals pledged?
The latest disclosed shareholding pattern shows no pledged promoter shares in Lincoln Pharmaceuticals.
How has Lincoln Pharmaceuticals's promoter holding changed in the last year?
Promoter holding moved from 49.78% in Sep 2025 to 49.78% in Sep 2026 (unchanged).
How many shareholders does Lincoln Pharmaceuticals have?
Lincoln Pharmaceuticals had 29,272 shareholders in Sep 2026, compared with 29,396 in Jun 2026.